Cyclin B-cdc2 complexes are kept inactive by inhibitory phosphorylatio
ns on Thr-14 and Tyr-15 of cdc2 until they are dephosphorylated at the
end of G2 by the phosphatase cdc25. Recent work has suggested that a
small region of cyclin B, which we call the P box, may contribute part
of a phosphatase-activating domain to cdc25. Individual conservative
substitutions at three invariant residues within the P box yield mutan
t cyclin 8 proteins that bind cdc2 in vitro and then show the predicte
d cell cycle arrest, with cdc25 remaining in the low activity interpha
se form and cyclin B-cdc2 complexes remaining phosphorylated and inact
ive. While the low activity interphase form of cdc25 cannot act on cdc
2 complexed with a mutant P box cyclin, the high activity M phase form
of cdc25 can. These results demonstrate that the P box domain of cycl
in B is required for cdc25 activation and support a two-step mechanism
for the cdc25-dependent activation of cyclin B-cdc2.